Clik here to view.
Alere cuts outlook as it probes accounting snafu
Alere (NYSE:ALR) yesterday cut its outlook for the rest of the year and said it plans to filed its delayed annual report for 2015 “as soon as practicable” as it probes accounting snafus in Africa and...
View ArticleClik here to view.
Health Canada approves Abbott’s Absorb bioresorbable stent
Abbott (NYSE:ABT) said yesterday that Health Canada approved its Absorb bioresorbable coronary stent. The Absorb everolimus-eluting stent, which is designed to dissolve completely after approximately...
View ArticleClik here to view.
Getinge’s Q2 profits jump despite flat sales
Getinge (PINK:GETI B) yesterday reported a 2nd-quarter profit gain of more than 28% despite flat sales for the 3 months ended June 30. The Swedish medical device giant posted profits of 227 million...
View ArticleClik here to view.
Medtronic launches new oblique lateral spine tech
Medtronic (NYSE:MDT) said today that it’s launching several new components for its oblique lateral spinal fusion system. Fridley, Minn.-based Medtronic said the Pivox system for its OLIF25 and...
View ArticleClik here to view.
Endonovo Therapeutics raises $10m for Rio Grande buy
Endonovo Therapeutics (OTC:ENDV) said today that it raised $10 million it plans to use to fund the $22 million acquisition of Rio Grande Neurosciences. The backing from an unnamed institutional...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for July 15, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
FDA approves Abbott’s Tecnis Symfony lens for cataracts
The FDA last week granted pre-market approval to the Tecnis Symfony intraocular lens made by Abbott Medical Optics (NYSE:ABT) for treating patients with cataracts. The device is the 1st intra-ocular...
View ArticleClik here to view.
The United Nations sustainable development goals: Efficient and effective...
Mary Lou Valdez, FDA’s Associate Commissioner for International Programs By Mary Lou Valdez and Kristin Wedding Do you think it’s possible to ensure healthy lives and promote well-being for all people...
View ArticleClik here to view.
Stryker’s Mako win a round in patent war with Smith & Nephew’s Blue Belt...
Stryker (NYSE:SYK) subsidiary Mako Surgical won a round in its patent war with Smith & Nephew‘s (NYSE:SNN) Blue Belt Technologies last week, after the U.S. Patent Trial & Appeal Board declared...
View ArticleClik here to view.
Magnetic Insight raises $3m for magnetic particle imaging
Magnetic Insight said today that it raised a $3 million seed round for the magnetic particle imaging technology it’s developing. Alameda, Calif.-based Magnetic Insight said Sand Hill Angels led the...
View ArticleClik here to view.
T2 Biosystems, Bayer ink blood disorder deal
T2 Biosystems (NSDQ:TTOO) said today that it inked a deal with Bayer (ETR:BAYN) for research on blood coagulation disorders. The deal calls for T2 to provide its T2MR magnetic resonance-based...
View ArticleClik here to view.
InVivo Therapeutics adds another clinical site
InVivo Therapeutics (NSDQ:NVIV) said today that it added another site to the clinical trial of its neurospinal scaffold, taking the total number of participating sites to 22. That includes the 1st...
View ArticleClik here to view.
Medtronic wins FDA nod for 2-level cervical fusion with Prestige LP spine...
Medtronic (NYSE:MDT) said today that the FDA approved 2-level cervical fusions using its Prestige LP spinal implant. “Medtronic is committed to elevating spine care by combining innovative new...
View ArticleClik here to view.
Intersect ENT jumps on strong Q2 prelims
Intersect ENT (NSDQ:XENT) shares jumped today after the medical device company reported preliminary 2nd-quarter sales numbers that beat the consensus forecast on Wall Street. Menlo Park, Calif.-based...
View ArticleClik here to view.
Titan Medical delays close for $16m placement with Chinese private equity firm
Titan Medical (CVE:TMD) added a month to the closing date on a private placement that’s slated to add about $16 million to its coffers. The placement with Chinese private equity player Shanghai Jugu...
View ArticleClik here to view.
Allergan asks FDA to approve Oculeve neurostim device
Allergan (NYSE:AGN) said today that it filed a de novo approval application with the FDA for its Oculeve nasal neurostimulation device for dry eye it bought last year. Oculeve is a hand-held device...
View ArticleClik here to view.
Zimmer pays at least $132m for French robot-assisted surgery firm Medtech SA
Zimmer Biomet (NYSE:ZBH) said today that it agreed to pay at least $132 million to acquire French robot-assisted surgery firm Medtech (EPA:ROSA). Warsaw, Ind.-based Zimmer Biomet has already paid...
View ArticleClik here to view.
Essential Medical wins CE Mark for Manta vascular closure device
Essential Medical said today that it won CE Mark approval in the European Union for its Manta vascular closure device. The device is designed to close punctures in less than 1 minute, providing...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for July 18, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Brazilian regulators allow more flexibility for device registration...
By Stewart Eisenhart, Emergo Group Brazilian medical device market regulator ANVISA has signaled that a new regulation providing more flexibility for transferring medical device registrations between...
View Article
